Ultragenyx Pharmaceutical Inc. buy Guggenheim
Start price
20.06.25
/
50%
€32.00
Target price
20.06.26
€55.59
Performance (%)
-40.63%
Price
08:48
?
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Ultragenyx Pharmaceutical Inc. is performing very badly with a performance of -40.63%. This prediction currently runs until 20.06.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 4.372% | 4.372% |
| iShares Core DAX® | -1.338% | -5.619% |
| iShares Nasdaq 100 | -1.067% | 2.598% |
| iShares Nikkei 225® | -1.991% | -6.512% |
| iShares S&P 500 | -1.316% | 0.905% |
Comments by Guggenheim for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $64.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Guggenheim for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€20.00
05.01.26
05.01.26
€44.47
05.01.27
05.01.27
-5.00%
08:48
08:48
